Loading...
Market
Will the FDA approve expanded clinical trials for gene-edited pig kidney transplants by end of 2025?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the FDA or related government agencies
Story
Alabama Woman, 53, Freed from Eight Years of Dialysis After Third Gene-Edited Pig Kidney Transplant in Late November
Dec 17, 2024, 03:22 PM
An Alabama woman, aged 53, is recovering well after receiving a gene-edited pig kidney transplant last month at NYU Langone Health. This transplant has freed her from eight years of dialysis, marking her as the third person to undergo such an experimental procedure. The surgery took place in late November and is part of ongoing efforts to explore xenotransplantation as a solution for organ shortages. Previous recipients of pig organs have faced severe complications, with all having died within two months post-transplant. However, the current recipient's condition is reported as 'extraordinary,' raising hopes for improved outcomes in future xenotransplant trials.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
NYU Langone • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Other • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Fully approved • 25%
Conditional approval • 25%
Still in experimental phase • 25%
Approval denied • 25%